EPILIZINE® CR 300


Prolonged release tablets
scheduling status
S3
registration number
A39/2.5/0039
What EPILIZINE® CR 300 contains
Each tablet contains199,8 mg sodium valproate and 87,0 mg valproic acid, equivalent to 300 mg sodium valproate.
other ingredients
Core: Hypromellose Ethyl cellulose Hydrated silica Film-coat: Violet coat containing: hypromellose, titanium dioxide (E171), macrogol 400, indigo carmine aluminium lake FD&C Blue No. 2 (E132), erythrosine BS aluminium lake (E127), iron oxide black (E172).
Therapeutic classification
N03AG01.
© 2026 SAHPRA. ALL RIGHTS RESERVED